Brief: AxoGen Q3 Revenue USD 48.6 Million Vs. IBES Estimate USD 47.1 Million
07/11/2024 12:00
Nov 07 (Reuters) - AxoGen Q3 adjusted net income USD 3.1 million vs. IBES estimate USD 259.8 thousand. * Q3 gross margin 74.9% * Q3 net income USD -1.9 million * Q3 adjusted EBITDA USD 6.5 million vs. IBES estimate USD 4.47 million * outlook FY revenue USD 182-186 million